Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
16,075,000
|
16,445,000
|
17,374,000
|
15,981,000
| Cost of Revenue | 12,097,000 | 11,836,000 | 12,478,000 | 11,441,000 | |
Gross Profit
|
3,978,000
|
4,609,000
|
4,896,000
|
4,540,000
| |
|
Operating Expenses |
|
Research Development | 613,000 | 634,000 | 632,000 | 587,000 |
|
Selling General and Administrative | 1,747,000 | 1,379,000 | 1,648,000 | 1,630,000 |
|
Non Recurring | 580,000 |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,038,000
|
2,596,000
|
2,616,000
|
2,323,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (11,000) | (17,000) | 70,000 | 88,000 |
|
Earnings Before Interest And Taxes | 1,027,000 | 2,579,000 | 2,686,000 | 2,411,000 |
|
Interest Expense | 115,000 | 129,000 | 110,000 | 113,000 |
|
Income Before Tax | 912,000 | 2,450,000 | 2,576,000 | 2,298,000 |
|
Income Tax Expense | 214,000 | 753,000 | 872,000 | 689,000 |
|
Minority Interest | (3,000) | (3,000) | (10,000) | (25,000) |
|
|
|
Net Income From Continuing Ops | 697,000 | 1,699,000 | 1,699,000 | 1,586,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
697,000
|
1,699,000
|
1,699,000
|
1,586,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
697,000
|
1,699,000
|
1,699,000
|
1,586,000
|
|